Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 7, 2008, Pages 846-851

  Grounds, Miranda D ^a   Radley, Hannah G ^a   Gebski, Bijanka L ^a   Bogoyevitch, Marie A ^b   Shavlakadze, Thea ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Inflammation; Insulin like growth factor 1; Necrosis; Skeletal muscle; Tumour necrosis factor

Indexed keywords

CORTICOSTEROID; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; CONTROLLED STUDY; DIET THERAPY; DUCHENNE MUSCULAR DYSTROPHY; GENE SILENCING; GENE THERAPY; HUMAN; INFLAMMATION; MOUSE; NONHUMAN; OSTEOPOROSIS; PROTEIN EXPRESSION; SIDE EFFECT; SKELETAL MUSCLE; WEIGHT GAIN;

EID: 44249095380     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04868.x     Document Type: Conference Paper

References (72)